Signaturefd, LLC Blueprint Medicines Corp Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Signaturefd, LLC holds 169 shares of BPMC stock, worth $15,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169

Previous 187 9.63%

Holding current value

$15,287

Previous $20,000 25.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$84.1 - $120.5 $1,513 - $2,169	-18 Reduced 9.63%	169 $15,000
Q2 2024 Jul 29, 2024	BUY	$85.18 - $108.78 $3,236 - $4,133	38 Added 25.5%	187 $20,000
Q4 2023 Jan 31, 2024	SELL	$43.96 - $92.84 $5,978 - $12,626	-136 Reduced 47.72%	149 $13,000
Q3 2023 Nov 03, 2023	SELL	$46.9 - $66.0 $328 - $462	-7 Reduced 2.4%	285 $14,000
Q2 2023 Aug 01, 2023	BUY	$42.2 - $66.37 $5,190 - $8,163	123 Added 72.78%	292 $18,000
Q1 2023 Apr 28, 2023	BUY	$37.97 - $50.0 $1,974 - $2,600	52 Added 44.44%	169 $7,000
Q4 2022 Jan 27, 2023	SELL	$41.06 - $66.48 $3,490 - $5,650	-85 Reduced 42.08%	117 $5,000
Q3 2022 Nov 08, 2022	SELL	$49.93 - $77.7 $3,045 - $4,739	-61 Reduced 23.19%	202 $13,000
Q2 2022 Aug 10, 2022	BUY	$45.23 - $70.15 $5,608 - $8,698	124 Added 89.21%	263 $13,000
Q1 2022 May 02, 2022	BUY	$54.1 - $110.08 $1,731 - $3,522	32 Added 29.91%	139 $9,000
Q4 2021 Jan 25, 2022	BUY	$94.25 - $115.99 $1,602 - $1,971	17 Added 18.89%	107 $11,000
Q3 2021 Oct 28, 2021	BUY	$80.98 - $109.47 $161 - $218	2 Added 2.27%	90 $9,000
Q2 2021 Jul 26, 2021	BUY	$82.78 - $101.0 $82 - $101	1 Added 1.15%	88 $8,000
Q1 2021 Apr 30, 2021	BUY	$90.71 - $108.28 $90 - $108	1 Added 1.16%	87 $8,000
Q3 2020 Nov 03, 2020	BUY	$66.45 - $92.7 $1,329 - $1,854	20 Added 30.3%	86 $8,000
Q1 2020 Apr 23, 2020	BUY	$48.11 - $82.22 $3,175 - $5,426	66 New	66 $4,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account